BellRing Brands (BRBR) Q3 2026 earnings review

Top-Line Stable, But Profitability Plummets Amid Serial Execution Missteps

BellRing Brands is facing a severe margin crisis. While Q3 net sales grew a stable 4.2% YoY to $570.4M, underlying profitability collapsed. Do not be fooled by the GAAP Net Income increasing 63% YoY—this is entirely an accounting artifact from lapping a $68.1M legal provision in the prior year. Adjusted EBITDA plunged 35% YoY to $78.3M, and margins compressed by over 800 basis points. The culprit: aggressive inflation, higher freight, sustained promotional pressures, and a new $10M charge for excess bottle inventory. Consequently, management slashed FY26 Adjusted EBITDA guidance by $40M to $275-$295M. Incoming CEO Michael Axelrod inherits a business with resilient category demand but severely impaired execution and cost controls.

🐂 Bull Case

Dymatize Rebounds Strongly

Dymatize sales surged 26.7% YoY, driven by strong international distribution and a massive 20.7% increase in price/mix, proving brand pricing power in the performance segment.

Category Tailwinds Persist

The RTD wellness category continues to grow (up 11% YoY). Premier Protein maintained its #1 market share at 21.9%, driven by distribution gains (TDPs up 27%) and stable underlying consumption (+6%).

🐻 Bear Case

Serial Inventory Mismanagement

The company recorded a $10M charge for excess shake bottles in Q3, directly following an $11.3M charge in Q2 for bad ingredients. Q4 will see another $7M hit in targeted trade spend just to clear the remaining excess inventory.

Profitability Slashed Again

FY26 Adjusted EBITDA guidance was cut again, dropping to an implied margin of roughly 12%—a stunning reversal from the 20.8% margin achieved in FY25. Input inflation, tariffs, and promotional intensity are structurally impairing margins.

⚖️ Verdict: 🔴

Bearish. While revenue growth is stable, the repeated downward revisions to EBITDA guidance, back-to-back inventory charges, and heavy reliance on promotional discounting point to deep operational issues that will take quarters to fix.

Key Themes

CONCERN NEW 🔴🔴

Serial Inventory and Supply Chain Missteps

Execution is faltering. Q3 results included a $10.0M pre-tax charge for 'excess shake bottle inventory.' This comes exactly one quarter after an $11.3M charge for a third-party supplied ingredient quality issue. Total FY26 unfavorable inventory impacts will reach $28M. Compounding the pain, management expects a $7M headwind in Q4 primarily from 'targeted trade spend' required to discount and clear this excess bottle inventory before year-end. This demonstrates a troubling inability to accurately forecast supply against retail demand.

CONCERN 🔴

Promotional Intensity Crushing Price/Mix

The 'perfect storm' of competitive intensity cited in Q2 continues to ravage margins. Premier Protein's price/mix declined 0.8% overall, with RTD shakes specifically seeing a 1.9% price/mix headwind driven by incremental promotional investment. While RTD volume grew 3.1%, the company is having to buy that growth. Adjusted gross margins fell steeply from 35.1% to 27.7% as inflation (including tariffs and freight) collided with lower net selling prices.

DRIVER 🟢

Dymatize Roars Back to Life

Accelerating. Dymatize was the brightest operational spot this quarter, with net sales surging 26.7% YoY. Notably, this was achieved with massive pricing power: price/mix increased 20.7%, paired with a 6.0% volume gain. Management attributed this to inflation-driven price increases sticking with consumers, alongside strong international distribution gains. This is a sharp reversal from Q2's 2% decline and proves the performance-nutrition brand has high consumer loyalty.

DRIVER 🟢

Distribution Gains Driving RTD Core

Stable. Despite margin woes, the underlying demand for Premier Protein RTD shakes remains robust. Total Distribution Points (TDPs) grew 27% YoY in Q3. Consumption grew 6.0% overall, led by massive strength in eCommerce (+50.9%) and Food (+26.1%), which successfully offset a 7.6% decline in the legacy Club channel. Household penetration for the RTD category expanded to 21.9%, indicating the long-term macro trend of wellness and high-protein diets remains intact.

THEME NEW

Leadership Transition Complete

Michael Axelrod officially assumed the role of President and CEO on July 29, 2026, taking over from long-time CEO Darcy Davenport. Axelrod steps into a difficult turnaround situation, noting his mandate to 'strengthen execution' and 'deliver more consistent, profitable growth.' His immediate challenge will be right-sizing the supply chain and deciding whether to sacrifice near-term market share to restore baseline pricing.

Other KPIs

Adjusted Gross Profit $157.9 million

Declined sharply by $34.5 million YoY. Adjusted gross profit margin compressed by 740 basis points to 27.7%. This excludes mark-to-market commodity hedges but includes the brutal reality of current input cost inflation, higher freight, and the $10M excess bottle charge.

Adjusted Net Earnings $35.0 million

Decelerating aggressively. Adjusted net earnings fell 50% YoY from $70.8 million. GAAP net earnings optically improved (+63%) only because the prior-year quarter was burdened by a one-time $68.1 million provision for legal matters. Removing the noise, underlying bottom-line profitability was cut in half.

Premier Protein Powders Sales Consumption -4.2%

Decelerating. While the RTD formats saw slight growth, the powder segment contracted. Management cited reduced distribution and negative elasticities stemming from recent inflation-driven price increases.

Guidance

FY26 Net Sales $2.335 - $2.375 billion

Stable. The midpoint of $2.355B represents ~1.7% YoY growth. This is a slight tweak from the prior guide of $2.325-$2.365B, indicating that volume and top-line demand are tracking slightly ahead of the company's pessimistic Q2 recalibration.

FY26 Adjusted EBITDA $275 - $295 million

Decelerating. This is a massive $40 million reduction from the previous guidance midpoint of $325 million issued just one quarter ago. It implies a full-year margin of ~12%, a staggering collapse from the 20.8% margin achieved in FY25.

FY26 Capital Expenditures $10 million

Stable. Up slightly from the $8 million targeted in previous quarters, reflecting ongoing asset-light operational maintenance.

Key Questions

Inventory Forecasting Autopsy

You've taken over $21 million in inventory-related charges in the last two quarters and are guiding for $7M in targeted trade spend to clear more. What structural changes is the new CEO implementing in supply chain forecasting to stop this bleeding?

The Path Back to 18-20% Margins

The long-term algorithm previously targeted 18-20% EBITDA margins. With FY26 now guided to ~12%, is the 18% floor still achievable, and if so, what is the realistic multi-year timeline to recover 600+ basis points of margin?

Dymatize Volume Elasticity

Dymatize achieved 6% volume growth alongside a massive 20.7% price/mix increase. Do you expect this level of pricing to stick without eventually causing severe volume destruction in upcoming quarters?

Promotional Strategy

With Premier Protein price/mix negative again due to incremental promotional investments, at what point does the company decide to step back from matching 'insurgent brand' promotions to protect the bottom line?